Skip to main content

Part of the book series: Atlas of Anatomic Pathology ((AAP))

  • 2515 Accesses

Abstract

The structure of the male breast is almost identical to that of the female breast, yet both benign and malignant breast neoplasms are rare in males. Until puberty, the male and female breasts are identical, composed of lactiferous ducts and fibrofatty stroma. In males, testosterone levels increase during puberty, causing involution and atrophy of the ducts. In females, both stroma and ducts proliferate and lobular units develop in response to oestrogen and progesterone. The normal adult male breast is composed primarily of a small nipple-areolar complex, subcutaneous adipose tissue, stromal elements, and a few poorly developed ductal structures that end blindly. Cooper ligaments are absent, and terminal ductal lobular unit formation is rare, which explains the rarity of many lesions such as cysts, fibroadenomas, phyllodes tumours, and lobular neoplasia. Most lesions in the male breast are of ductal origin.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Murray MP, Brogi E. Benign proliferative lesions of male breast. In: Hoda SA, Brogi E, Koerner FC, Rosen PR, editors. Rosen’s breast pathology. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2014. p. 957–69.

    Google Scholar 

  2. Tavassoli FA, Eusebi V. Tumors of the mammary gland: atlas of tumor pathology. 4th series, fascicle 10. Washington, DC: American Registry of Pathology, Armed Forces Institute of Pathology; 2009.

    Google Scholar 

  3. Nguyen C, Kettler MD, Swirsky ME, Miller VI, Scott C, Krause R, Hadro JA. Male breast disease: pictorial review with radiologic-pathologic correlation. Radiographics. 2013;33:763–79.

    Article  PubMed  Google Scholar 

  4. Lemaine V, Simmons P. The adolescent female: breast and reproductive embryology and anatomy. Clin Anat. 2013;26:22–8.

    Article  PubMed  Google Scholar 

  5. Chau A, Jafarian N, Rosa M. Male breast: clinical and imaging evaluations of benign and malignant entities with histologic correlation. Am J Med. 2016;129:776–91.

    Article  PubMed  Google Scholar 

  6. Tangerud Å, Potapenko I, Skjerven HK, Stensrud MJ. Radiologic evaluation of lumps in the male breast. Acta Radiol. 2016;57:809–14.

    Article  PubMed  Google Scholar 

  7. Anderson JA, Gram JB. Male breast at autopsy. Acta Pathol Microbiol Immunol Scand. 1982;90:191–7.

    Google Scholar 

  8. Ladizinski B, Lee KC, Nutan FN, Higgins 2nd HW, Federman DG. Gynecomastia: etiologies, clinical presentations, diagnosis, and management. South Med J. 2014;107:44–9.

    Article  PubMed  Google Scholar 

  9. Ersöz H, Onde ME, Terekeci H, Kurtoglu S, Tor H. Causes of gynaecomastia in young adult males and factors associated with idiopathic gynaecomastia. Int J Androl. 2002;25:312–6.

    Article  Google Scholar 

  10. Johnson RE, Murad MH. Gynecomastia: pathophysiology, evaluation, and management. Mayo Clin Proc. 2009;84:1010–5.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Lapid O, Jolink F, Meijer SL. Pathological findings in gynecomastia: analysis of 5113 breasts. Ann Plast Surg. 2015;74:163–6.

    Article  CAS  PubMed  Google Scholar 

  12. Ng AM, Dissanayake D, Metcalf C, Wylie E. Clinical and imaging features of male breast disease, with pathological correlation: a pictorial essay. J Med Imaging Radiat Oncol. 2014;58:189–98.

    Article  PubMed  Google Scholar 

  13. Hong JH, Ha KS, Jung YH, Won HS, An HJ, Lee GJ, et al. Clinical features of male breast cancer: experiences from seven institutions over 20 years. Cancer Res Treat. 2016;48(4):1389.

    Google Scholar 

  14. Georgiadis E, Papandreou L, Evangelopoulou C, Aliferis C, Lymberis C, Panitsa C, Batrinos M. Incidence of gynaecomastia in 954 young males and its relationship to somatometric parameters. Ann Hum Biol. 1994;21:579–87.

    Article  CAS  PubMed  Google Scholar 

  15. Nordt CA, DiVasta AD. Gynecomastia in adolescents. Curr Opin Pediatr. 2008;20:375–82.

    Article  PubMed  Google Scholar 

  16. Nicolis GL, Modlinger RS, Gabrilove JL. A study of the histopathology of human gynecomastia. J Clin Endocrinol Metab. 1971;32:173–8.

    Article  CAS  PubMed  Google Scholar 

  17. Oates SD. Gynecomastia. In: Babiera GV, Skoracki RJ, Esteva FJ, editors. Advanced therapy of breast disease. 3rd ed. Shelton: People’s Medical Publishing House–USA; 2012. p. 271–94.

    Google Scholar 

  18. Bembo SA, Carlson HE. Gynecomastia: its features, and when and how to treat it. Cleve Clin J Med. 2004;71:511–7.

    Article  PubMed  Google Scholar 

  19. Cuhaci N, Polat SB, Evranos B, Ersoy R, Cakir B. Gynecomastia: clinical evaluation and management. Indian J Endocrinol Metab. 2014;18:150–8.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Gatalica Z, Norris BA, Kovatich AJ. Immunohistochemical localization of prostate-specific antigen in ductal epithelium of male breast. Potential diagnostic pitfall in patients with gynecomastia. Appl Immunohistochem Mol Morphol. 2000;8:158–61.

    CAS  PubMed  Google Scholar 

  21. Wells JM, Liu Y, Ginter PS, Nguyen MT, Shin SJ. Elucidating encounters of atypical ductal hyperplasia arising in gynaecomastia. Histopathology. 2015;66(3):398–408.

    Google Scholar 

  22. Sasco AJ, Lowenfels AB, Pasker-de Jong P. Review article: epidemiology of male breast cancer. A meta-analysis of published case-control studies and discussion of selected aetiological factors. Int J Cancer. 1993;53:538–49.

    Article  CAS  PubMed  Google Scholar 

  23. Anderson WF, Jatoi I, Tse J, Rosenberg PS. Male breast cancer: a population-based comparison with female breast cancer. J Clin Oncol. 2010;28:232–9.

    Article  PubMed  Google Scholar 

  24. Giordano SH, Cohen DS, Buzdar AU, Perkins G, Hortobagyi GN. Breast carcinoma in men: a population-based study. Cancer. 2004;101:51–7.

    Article  PubMed  Google Scholar 

  25. Miao H, Verkooijen HM, Chia KS, Bouchardy C, Pukkala E, Laronningen S, et al. Incidence and outcome of male breast cancer: an international population-based study. J Clin Oncol. 2011;29:4381–6.

    Article  PubMed  Google Scholar 

  26. Greif JM, Pezzi CM, Klimberg VS, Bailey L, Zuraek M. Gender differences in breast cancer: analysis of 13,000 breast cancers in men from the National Cancer Data Base. Ann Surg Oncol. 2012;19:3199–204.

    Article  PubMed  Google Scholar 

  27. Ly D, Forman D, Ferlay J, Brinton LA, Cook MB. An international comparison of male and female breast cancer incidence rates. Int J Cancer. 2013;132:1918–26.

    Article  CAS  PubMed  Google Scholar 

  28. Ferzoco RM, Ruddy KJ. The epidemiology of male breast cancer. Curr Oncol Rep. 2016;18:1.

    Article  CAS  PubMed  Google Scholar 

  29. Masci G, Caruso M, Caruso F, Salvini P, Carnaghi C, Giordano L, et al. Clinicopathological and immunohistochemical characteristics in male breast cancer: a retrospective case series. Oncologist. 2015;20:586–92.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Sanguinetti A, Polistena A, Lucchini R, Monacelli M, Galasse S, Avenia S, et al. Male breast cancer, clinical presentation, diagnosis and treatment: twenty years of experience in our Breast Unit. Int J Surg Case Rep. 2016;20S:8–11.

    Article  CAS  PubMed  Google Scholar 

  31. Tai YC, Domchek S, Parmigiani G, Chen S. Breast cancer risk among male BRCA1 and BRCA2 mutation carriers. J Natl Cancer Inst. 2007;99:1811–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Deb S, Wong SQ, Li J, Do H, Weiss J, Byrne D, et al. Mutational profiling of familial male breast cancers reveals similarities with luminal A female breast cancer with rare TP53 mutations. Br J Cancer. 2014;111:2351–60.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Silvestri V, Barrowdale D, Mulligan AM, Neuhausen SL, Fox S, Karlan BY, et al. Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2. Breast Cancer Res. 2016;18:15.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Deb S, Lakhani SR, Ottini L. Fox SB The cancer genetics and pathology of male breast cancer. Histopathology. 2016;68:110–8.

    Article  PubMed  Google Scholar 

  35. Brinton LA, Richesson DA, Gierach GL, Lacey Jr JV, Park Y, Hollenbeck AR, Schatzkin A. Prospective evaluation of risk factors for male breast cancer. J Natl Cancer Inst. 2008;100:1477–81.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Chavez-Macgregor M, Clarke CA, Lichtensztajn D, Hortobagyi GN, Giordano SH. Male breast cancer according to tumor subtype and race: a population-based study. Cancer. 2013;119:1611–7.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Mathew J, Perkins GH, Stephens T, Middleton LP, Yang WT. Primary breast cancer in men: clinical, imaging, and pathologic findings in 57 patients. AJR Am J Roentgenol. 2008;191:1631–9.

    Article  PubMed  Google Scholar 

  38. Yen PP, Sinha N, Barnes PJ, Butt R, Iles S. Benign and malignant male breast diseases: radiologic and pathologic correlation. Can Assoc Radiol J. 2015;66:198–207.

    Article  PubMed  Google Scholar 

  39. Khalkhali I, Cho J. Male breast cancer imaging. Breast J. 2015;21:217–8.

    Article  PubMed  Google Scholar 

  40. Carrasco RM, Benito MA, Gomariz EM, Povedano JLR, Paredes MM. Mammography and ultrasound in the evaluation of male breast disease. Eur Radiol. 2010;20:2797–805.

    Article  Google Scholar 

  41. Yu XF, Yang HJ, Yu Y, Zou DH, Miao LL. A prognostic analysis of male breast cancer (MBC) compared with post-menopausal female breast cancer (FBC). PLoS One. 2015;10:e0136670.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Muir D, Kanthan R, Kanthan SC. Male versus female breast cancers. A population-based comparative immunohistochemical analysis. Arch Pathol Lab Med. 2003;127:36–41.

    CAS  PubMed  Google Scholar 

  43. Kao L, Bulkin Y, Fineberg S, Montgomery L, Koenigsberg T. A case report: lobular carcinoma in situ in a male patient with subsequent invasive ductal carcinoma identified on screening breast MRI. J Cancer. 2012;3:226–30.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Leone JP, Leone J, Zwenger AO, Iturbe J, Vallejo CT, Leone BA. Prognostic significance of tumor subtypes in male breast cancer: a population-based study. Breast Cancer Res Treat. 2015;152:601–9.

    Article  CAS  PubMed  Google Scholar 

  45. Akita M, Kusunoki N, Nakajima T, Takase S, Maekawa Y, Kajimoto K, Ohno M. Paget's disease of the male breast: a case report. Surg Case Rep. 2015;1:103.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Zografos E, Gazouli M, Tsangaris G, Marinos E. The significance of proteomic biomarkers in male breast cancer. Cancer Genomics Proteomics. 2016;13:183–90.

    CAS  PubMed  Google Scholar 

  47. Kornegoor R, Verschuur-Maes AH, Buerger H, Hogenes MC, de Bruin PC, Oudejans JJ, et al. Molecular subtyping of male breast cancer by immunohistochemistry. Mod Pathol. 2012;25:398–404.

    Article  CAS  PubMed  Google Scholar 

  48. Wenhui Z, Shuo L, Dabei T, Ying P, Zhipeng W, Lei Z, et al. Androgen receptor expression in male breast cancer predicts inferior outcome and poor response to tamoxifen treatment. Eur J Endocrinol. 2014;171:527–33.

    Article  PubMed  Google Scholar 

  49. Leach IH, Ellis IO, Elston CW. c-erb-B-2 expression in male breast carcinoma. J Clin Pathol. 1992;45:942.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Kraus TS, Cohen C, Siddiqui MT. Prostate-specific antigen and hormone receptor expression in male and female breast carcinoma. Diagnostic Pathology. 2010;5:63. doi: 1596-5-63.

    Google Scholar 

  51. Kidwai N, Gong Y, Sun X, Deshpande CG, Yeldandi AV, Rao MS, Badve S. Expression of androgen receptor and prostate-specific antigen in male breast carcinoma. Breast Cancer Res. 2004;6(1):R18–23.

    Google Scholar 

  52. Henriques Abreu M, Henriques Abreu P, Afonso N, Pereira D, Henrique R, Lopesv C. Patterns of recurrence and treatment in male breast cancer: a clue to prognosis? Int J Cancer. 2016;139(8):1715–20.

    Google Scholar 

  53. Abreu MH, Afonso N, Abreu PH, Menezes F, Lopes P, Henrique R, et al. Male breast cancer: looking for better prognostic subgroups. Breast. 2016;26:18–24.

    Article  PubMed  Google Scholar 

  54. Piscuoglio S, Ng CK, Murray MP, Guerini-Rocco E, Martelotto LG, Geyer FC, et al. The genomic landscape of male breast cancers. Clin Cancer Res. 2016;22(16):4045–56.

    Google Scholar 

  55. Fentiman IS. Male breast cancer is not congruent with the female disease. Crit Rev Oncol Hematol. 2016;101:119–24.

    Article  PubMed  Google Scholar 

  56. Flynn LW, Park J, Patil SM, Cody 3rd HS, Port ER. Sentinel lymph node biopsy is successful and accurate in male breast carcinoma. J Am Coll Surg. 2008;206:616–21.

    Article  PubMed  Google Scholar 

  57. Khan MH, Allerton R, Pettit L. Hormone therapy for breast cancer in men. Clin Breast Cancer. 2015;15:245–50.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer Science+Business Media LLC

About this chapter

Cite this chapter

Tan, P.H., Sahin, A.A. (2017). Male Breast Lesions. In: Atlas of Differential Diagnosis in Breast Pathology. Atlas of Anatomic Pathology. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-6697-4_14

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-6697-4_14

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-6695-0

  • Online ISBN: 978-1-4939-6697-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics